WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005067891) COMPOSITIONS COMPROSING MEMANTINE AND POLYANIONIC POLYMERS FOR ADMINISTRATION TO THE EYE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2005/067891    International Application No.:    PCT/US2005/000249
Publication Date: 28.07.2005 International Filing Date: 04.01.2005
Chapter 2 Demand Filed:    15.08.2005    
IPC:
A61K 9/00 (2006.01), A61K 31/13 (2006.01), A61K 47/38 (2006.01)
Applicants: ALLERGAN, INC. [US/US]; 2525 Dupont Drive, Irvine, CA 92612 (US) (For All Designated States Except US).
HUGHES, Patrick, M. [US/US]; (US) (For US Only).
OLEJNIK, Orest [US/US]; (US) (For US Only).
SCHIFFMAN, Rhett [US/US]; (US) (For US Only)
Inventors: HUGHES, Patrick, M.; (US).
OLEJNIK, Orest; (US).
SCHIFFMAN, Rhett; (US)
Agent: FISHER, Carlos, A.; c/o Allergan Sales, Inc., 2525 Dupont Drive, Irvine, CA 92612 (US)
Priority Data:
10/752,125 05.01.2004 US
10/941,272 14.09.2004 US
Title (EN) COMPOSITIONS COMPROSING MEMANTINE AND POLYANIONIC POLYMERS FOR ADMINISTRATION TO THE EYE
(FR) COMPOSITIONS RENFERMANT DE LA MEMANTINE ET DES POLYMERES POLYANIONIQUES POUR ADMINISTRATION DANS L'OEIL
Abstract: front page image
(EN)Compositions are provided including a neuroprotective amine related to adamantane and a polyanionic polymer which are well tolerated, non-toxic and/or result in reduced or fewer side effects. Methods are provided employing such compositions, for example, topically administering such compositions to human or animal eyes, for treating human or animal eyes.
(FR)L'invention concerne des compositions qui renferment une amine neuroprotectrice liée à l'adamantane et un polymère polyanionique bien tolérés, non toxiques et/ou entraînant des effets secondaires réduits ou moins nombreux. L'invention concerne aussi des procédés reposant sur ces compositions, par exemple pour l'administration topique de ces compositions à l'oeil humain ou animal, pour le traitement oculaire correspondant.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)